Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease

Neurology
W G OndoT A Zesiewicz

Abstract

To evaluate the efficacy and tolerability of lubiprostone (Amitiza) for constipation in Parkinson disease (PD) in a double-blind, randomized, controlled study. Patients with PD and clinically meaningful constipation (constipation rating scale score > 10 [range: 0-28]) were recruited from 2 academic movement disorder centers to participate in the study. After enrollment, patients were initially followed for 2 weeks and then were randomly assigned 1:1 to lubiprostone, and the dose was titrated up to 48 μg/day. They returned 4 weeks later for a final assessment. Data included stool diaries and global impressions (co-primary endpoints), demographics, Unified Parkinson's Disease Rating Scale scores, constipation scale scores, visual analog scale (VAS) scores, a stool diary, and adverse events. Fifty-four subjects (39 male, mean age 67.0 ± 10.1 years, and mean duration of PD 8.3 ± 5.4 years) were randomly assigned to lubiprostone or placebo. One patient in the drug group discontinued the study because of logistics, and one patient in the placebo group discontinued the study because of lack of efficacy. A marked or very marked clinical global improvement was reported by 16 of 25 (64.0%) subjects receiving drug vs 5 of 27 (18.5%) subje...Continue Reading

Associated Clinical Trials

May 25, 2009·Christine Hunter, Christine Hunter

Citations

Nov 14, 2013·Current Treatment Options in Neurology·Brendon P BootBradley F Boeve
Feb 27, 2013·Clinical Interventions in Aging·Beatriz Gras-Miralles, Filippo Cremonini
Dec 30, 2014·Expert Opinion on Pharmacotherapy·Malco RossiSantiago Perez-Lloret
Feb 5, 2013·Expert Opinion on Emerging Drugs·Santiago Perez-LloretOlivier Rascol
May 8, 2015·Internal Medicine·Yuri IwataKoichiro Yoshie
Sep 16, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragKallol Ray Chaudhuri
Sep 26, 2015·Journal of Parkinson's Disease·Lisa Klingelhoefer, Heinz Reichmann
May 20, 2015·Lancet Neurology·Alfonso FasanoRonald F Pfeiffer
Apr 12, 2016·British Journal of Clinical Pharmacology·Aisha D AugustinR John Dobbs
May 27, 2015·American Journal of Alzheimer's Disease and Other Dementias·Farzana PervinCarol F Lippa
Oct 27, 2018·Current Treatment Options in Neurology·Ronald F Pfeiffer
Jan 20, 2018·Current Gastroenterology Reports·Amol SharmaSatish S C Rao
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Klaus SeppiUNKNOWN the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders So
Jul 11, 2019·Current Treatment Options in Neurology·Louise M Allan
Jan 21, 2020·Expert Opinion on Pharmacotherapy·Cecilia QuarracinoSantiago Pérez-Lloret
Feb 19, 2020·Expert Opinion on Emerging Drugs·Dinkar KulshreshthaMandar Jog
Aug 14, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ronald F Pfeiffer
Jan 5, 2017·Parkinson's Disease·Andrée-Anne PoirierDenis Soulet
Jun 9, 2017·Current Gastroenterology Reports·Elizabeth S John, Sita Chokhavatia
Jan 31, 2020·Continuum : Lifelong Learning in Neurology·Jalesh N Panicker, Ryuji Sakakibara
Feb 11, 2020·Expert Opinion on Pharmacotherapy·Shilan MozaffariMohammad Abdollahi
Jul 20, 2016·World Journal of Gastroenterology : WJG·Adreesh MukherjeeShyamal Kumar Das
Nov 23, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Karoline KnudsenPer Borghammer
Aug 9, 2018·Arquivos De Gastroenterologia·Juan Sebastian LasaIgnacio Zubiaurre
Sep 29, 2019·Journal of the Anus, Rectum and Colon·Ryuji SakakibaraShin Fukudo
Mar 7, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Jose-Alberto Palma, Horacio Kaufmann
Nov 29, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Kathryn A Chung, Ronald F Pfeiffer
Dec 18, 2020·Arquivos De Gastroenterologia·Maria do Carmo F PassosLuciana S Guedes
Feb 2, 2021·Expert Review of Neurotherapeutics·Katarina RukavinaK Ray Chaudhuri
Feb 5, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ryuji Sakakibara
Feb 16, 2021·The Journal of Clinical Investigation·Michael Camilleri
Apr 17, 2021·Annals of Medicine·Elisa MenozziAnthony H V Schapira
Jul 2, 2019·Clinical Parkinsonism & Related Disorders·Robert A HauserDenise Barbut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.